SIGHT SCIENCES, INC. Pre-Tax Income
SIGHT SCIENCES, INC. (SGHT) reported Pre-Tax Income of -$4.42 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest · last filed 2026-08-05
- SIGHT SCIENCES, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2026-06-30 was -$4.42M.
- SIGHT SCIENCES, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2026-03-31 was -$12.97M.
- SIGHT SCIENCES, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2025-12-31 was -$4.15M.
- SIGHT SCIENCES, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2025-09-30 was -$8.25M.
- SIGHT SCIENCES, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2025 was -$38.42M.
- SIGHT SCIENCES, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2024 was -$51.27M.
- SIGHT SCIENCES, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2023 was -$55.44M.
- SIGHT SCIENCES, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2022 was -$86.19M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$4.42M 10-Q · filed 2026-08-05 | -$17.39M 10-Q · filed 2026-08-05 | -$21.54M derived: sum of 3 quarters · filed 2026-08-05 | -$29.79M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$12.97M 10-Q · filed 2026-05-06 | -$17.12M derived: sum of 2 quarters · filed 2026-05-06 | -$25.37M derived: sum of 3 quarters · filed 2026-05-06 | -$37.27M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$4.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$12.40M derived: sum of 2 quarters · filed 2026-03-04 | -$24.30M derived: sum of 3 quarters · filed 2026-08-05 | -$38.42M 10-K · filed 2026-03-04 |
| 2025-09-30 | -$8.25M 10-Q · filed 2025-11-06 | -$20.15M derived: sum of 2 quarters · filed 2026-08-05 | -$34.26M 10-Q · filed 2025-11-06 | -$46.07M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$11.90M 10-Q · filed 2026-08-05 | -$26.01M 10-Q · filed 2026-08-05 | -$37.82M derived: sum of 3 quarters · filed 2026-08-05 | -$48.72M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$14.11M 10-Q · filed 2026-05-06 | -$25.92M derived: sum of 2 quarters · filed 2026-05-06 | -$36.82M derived: sum of 3 quarters · filed 2026-05-06 | -$49.13M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$11.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$22.71M derived: sum of 2 quarters · filed 2026-03-04 | -$35.02M derived: sum of 3 quarters · filed 2026-03-04 | -$51.27M 10-K · filed 2026-03-04 |
| 2024-09-30 | -$10.90M 10-Q · filed 2025-11-06 | -$23.21M derived: sum of 2 quarters · filed 2025-11-06 | -$39.46M 10-Q · filed 2025-11-06 | -$50.14M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$12.31M 10-Q · filed 2025-08-07 | -$28.56M 10-Q · filed 2025-08-07 | -$39.24M derived: sum of 3 quarters · filed 2025-08-07 | -$52.20M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$16.25M 10-Q · filed 2025-05-08 | -$26.93M derived: sum of 2 quarters · filed 2025-05-08 | -$39.89M derived: sum of 3 quarters · filed 2025-05-08 | -$54.63M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$10.68M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | -$23.64M derived: sum of 2 quarters · filed 2025-03-07 | -$38.38M derived: sum of 3 quarters · filed 2025-03-07 | -$55.44M 10-K · filed 2025-03-07 |
| 2023-09-30 | -$12.96M 10-Q · filed 2024-11-07 | -$27.70M derived: sum of 2 quarters · filed 2024-11-07 | -$44.76M 10-Q · filed 2024-11-07 | -$61.65M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$14.75M 10-Q · filed 2024-08-02 | -$31.80M 10-Q · filed 2024-08-02 | -$48.70M derived: sum of 3 quarters · filed 2024-08-02 | -$70.91M derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | -$17.05M 10-Q · filed 2024-05-06 | -$33.95M derived: sum of 2 quarters · filed 2024-05-06 | -$56.16M derived: sum of 3 quarters · filed 2024-05-06 | -$79.99M derived: sum of 4 quarters · filed 2024-05-06 |
| 2022-12-31 | -$16.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | -$39.11M derived: sum of 2 quarters · filed 2024-03-13 | -$62.94M derived: sum of 3 quarters · filed 2024-03-13 | -$86.19M 10-K · filed 2024-03-13 |
| 2022-09-30 | -$22.21M 10-Q · filed 2023-11-07 | -$46.04M derived: sum of 2 quarters · filed 2023-11-07 | -$69.30M 10-Q · filed 2023-11-07 | -$85.14M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$23.83M 10-Q · filed 2023-08-07 | -$47.09M 10-Q · filed 2023-08-07 | -$62.93M derived: sum of 3 quarters · filed 2023-08-07 | -$80.08M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | -$23.25M 10-Q · filed 2023-05-08 | -$39.09M derived: sum of 2 quarters · filed 2023-05-08 | -$56.24M derived: sum of 3 quarters · filed 2023-05-08 | -$73.84M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | -$15.84M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$32.99M derived: sum of 2 quarters · filed 2023-03-16 | -$50.58M derived: sum of 3 quarters · filed 2023-03-16 | -$62.77M 10-K · filed 2023-03-16 |
| 2021-09-30 | -$17.15M 10-Q · filed 2022-11-10 | -$34.75M derived: sum of 2 quarters · filed 2022-11-10 | -$46.93M 10-Q · filed 2022-11-10 | -$56.02M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$17.59M 10-Q · filed 2022-08-11 | -$29.78M 10-Q · filed 2022-08-11 | -$38.87M derived: sum of 3 quarters · filed 2022-08-11 | -$46.96M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$12.19M 10-Q · filed 2022-05-10 | -$21.28M derived: sum of 2 quarters · filed 2022-05-10 | -$29.37M derived: sum of 3 quarters · filed 2022-05-10 | -$37.68M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | -$9.09M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | -$17.18M derived: sum of 2 quarters · filed 2022-03-24 | -$25.49M derived: sum of 3 quarters · filed 2022-03-24 | -$34.63M 10-K · filed 2022-03-24 |
| 2020-09-30 | -$8.09M 10-Q · filed 2021-11-10 | -$16.40M derived: sum of 2 quarters · filed 2021-11-10 | -$25.54M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | -$8.31M 10-Q · filed 2021-08-12 | -$17.45M 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |